193 related articles for article (PubMed ID: 35184459)
21. Prognostic factors in patients with pathologic T1-2N1M0 disease in non-small cell carcinoma of the lung.
Matsuoka K; Sumitomo S; Misaki N
J Thorac Oncol; 2007 Dec; 2(12):1098-102. PubMed ID: 18090581
[TBL] [Abstract][Full Text] [Related]
22. Unfavorable prognosis of patients with stage II non-small cell lung cancer associated with macroscopic nodal metastases.
Yoshino I; Nakanishi R; Osaki T; Takenoyama M; Taga S; Hanagiri T; Yasumoto K
Chest; 1999 Jul; 116(1):144-9. PubMed ID: 10424518
[TBL] [Abstract][Full Text] [Related]
23. Analysis of predictive factors for postoperative survival for non small cell lung carcinoma patients with unexpected mediastinal lymph nodes metastasis.
Wang S; Zhou W; Zhang H; Zhao M; Chen X
Thorac Cardiovasc Surg; 2014 Mar; 62(2):126-32. PubMed ID: 23585223
[TBL] [Abstract][Full Text] [Related]
24. Postoperative survival effect of the number of examined lymph nodes on esophageal squamous cell carcinoma with pathological stage T1-3N0M0.
Wu LL; Zhong JD; Zhu JL; Kang L; Huang YY; Lin P; Long H; Zhang LJ; Ma QL; Qiu LH; Ma GW
BMC Cancer; 2022 Jan; 22(1):118. PubMed ID: 35090428
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for local recurrence after lobectomy and lymph node dissection in patients with non-small cell lung cancer: Implications for adjuvant therapy.
Isaka M; Kojima H; Takahashi S; Omae K; Ohde Y
Lung Cancer; 2018 Jan; 115():28-33. PubMed ID: 29290258
[TBL] [Abstract][Full Text] [Related]
26. Patterns of lymph node recurrence after radical surgery impacting on survival of patients with pT1-3N0M0 thoracic esophageal squamous cell carcinoma.
Chen XL; Chen TW; Fang ZJ; Zhang XM; Li ZL; Li H; Tang HJ; Zhou L; Wang D; Zhang Z
J Korean Med Sci; 2014 Feb; 29(2):217-23. PubMed ID: 24550648
[TBL] [Abstract][Full Text] [Related]
27. [Two patterns of mediastinal lymph node resection for non-small cell lung cancer of stage IIIA: survival analysis of 219 cases].
Zhang GQ; Han F; Gao SL; A DL; Pang ZL
Ai Zheng; 2007 May; 26(5):519-23. PubMed ID: 17672944
[TBL] [Abstract][Full Text] [Related]
28. Prognostic relevance of regional lymph-node distribution in patients with N1-positive non-small cell lung cancer: A retrospective single-center analysis.
Eichhorn F; Klotz LV; Muley T; Kobinger S; Winter H; Eichhorn ME
Lung Cancer; 2019 Dec; 138():95-101. PubMed ID: 31678832
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of log odds of positive lymph nodes in predicting the survival of patients with non-small cell lung cancer treated with neoadjuvant therapy and surgery: a SEER cohort-based study.
Wang Q; Wang S; Sun Z; Cao M; Zhao X
BMC Cancer; 2022 Jul; 22(1):801. PubMed ID: 35858848
[TBL] [Abstract][Full Text] [Related]
30. [Factors influencing survival and recurrence and potential significance of postoperative radiotherapy and adjuvant chemotherapy for stage ⅢA-N2 non-small cell lung cancer].
Han W; Song YZ; He M; Li J; Zhang R; Qiao XY
Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):861-867. PubMed ID: 27998447
[No Abstract] [Full Text] [Related]
31. Feasibility of nodal classification for non-small cell lung cancer by merging current N categories with the number of involved lymph node stations.
Chen W; Zhang C; Wang G; Yu Z; Liu H
Thorac Cancer; 2019 Jul; 10(7):1533-1543. PubMed ID: 31207184
[TBL] [Abstract][Full Text] [Related]
32. Lymph-node ratio predicts survival among the different stages of non-small-cell lung cancer: a multicentre analysis†.
Chiappetta M; Leuzzi G; Sperduti I; Bria E; Mucilli F; Lococo F; Spaggiari L; Ratto GB; Filosso PL; Facciolo F
Eur J Cardiothorac Surg; 2019 Mar; 55(3):405-412. PubMed ID: 30202953
[TBL] [Abstract][Full Text] [Related]
33. The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer.
Qiu C; Dong W; Su B; Liu Q; Du J
J Thorac Oncol; 2013 Apr; 8(4):429-35. PubMed ID: 23486264
[TBL] [Abstract][Full Text] [Related]
34. [Analysis of the relationship between the number of lymph nodes examined and prognosis for curatively resected gallbladder carcinoma: a multi-institutional study].
Zhang R; Wu YH; Zhang D; Zhang YJ; Qiu YH; Yang N; Song TQ; Lou JY; Li JT; Mao XH; Li SP; Si SB; Cai ZQ; Chen C; Geng ZM; Tang ZH
Zhonghua Wai Ke Za Zhi; 2020 Apr; 58(4):303-309. PubMed ID: 32241061
[No Abstract] [Full Text] [Related]
35. Survival Implications of Variation in the Thoroughness of Pathologic Lymph Node Examination in American College of Surgeons Oncology Group Z0030 (Alliance).
Osarogiagbon RU; Decker PA; Ballman K; Wigle D; Allen MS; Darling GE
Ann Thorac Surg; 2016 Aug; 102(2):363-9. PubMed ID: 27262908
[TBL] [Abstract][Full Text] [Related]
36. [Postoperative survival analysis of patients with stage Ⅲ-pN2 non-small cell lung cancer].
Wu XW; Chen T; Yin S; Deng Y; Zhao B
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):782-786. PubMed ID: 30392344
[No Abstract] [Full Text] [Related]
37. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
[TBL] [Abstract][Full Text] [Related]
38. Prognostic variability among nonsmall cell lung cancer patients with pathologic N1 lymph node involvement. Epidemiological figures with strong clinical implications.
Caldarella A; Crocetti E; Comin CE; Janni A; Pegna AL; Paci E
Cancer; 2006 Aug; 107(4):793-8. PubMed ID: 17024758
[TBL] [Abstract][Full Text] [Related]
39. Is tumor diameter a risk factor for occult N1 metastasis in patients with peripheral non-small cell lung cancer which is smaller than 3 cm?
Sayan M; Celik A; Kankoc A; Akarsu I; Aslan MT; Kurtoglu A; Ahmedova G; Tastepe AI
Updates Surg; 2023 Dec; 75(8):2335-2342. PubMed ID: 37382803
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors after surgical resection of N1 non-small cell lung cancer.
Mordant P; Pricopi C; Legras A; Arame A; Foucault C; Dujon A; Le Pimpec-Barthes F; Riquet M
Eur J Surg Oncol; 2015 May; 41(5):696-701. PubMed ID: 25454825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]